false
Catalog
#AACE2021: Top 20
Obesity, Genetics, Precision Medicine
Obesity, Genetics, Precision Medicine
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
In the video, Dr. Megan R. Haymart, a thyroid cancer expert and professor of medicine at the University of Michigan, discusses the epidemiology and management of thyroid cancer in 2021. She highlights that thyroid cancer is common, particularly among women, young adults, and individuals with a family history or previous radiation treatment. Overdiagnosis is a significant concern in thyroid cancer, leading to unnecessary treatments and potential harms. Efforts have been made to address this issue, such as guidelines recommending against routine thyroid ultrasound for patients with abnormal thyroid function but no palpable abnormalities. Dr. Haymart emphasizes the importance of individualized treatment decisions based on risk factors, including using less extensive surgery like lobectomy instead of total thyroidectomy for low-risk cases, and considering active surveillance for small, low-risk tumors. She calls for further research to improve risk stratification and reduce overdiagnosis and overtreatment in thyroid cancer management.<br /><br />Speaker: Dr. Megan R. Haymart - Professor of Medicine at the University of Michigan, focusing on thyroid cancer.
Asset Subtitle
Sadaf Farooqi, MBChB, PhD, FRCP | Monica Agarwal, MD, MEHP, FACE
Asset Caption
Slides unavailable
Keywords
video
Dr. Megan R. Haymart
thyroid cancer
epidemiology
management
2021
common
women
young adults
family history
overdiagnosis
unnecessary treatments
guidelines
individualized treatment decisions
risk factors
×
Please select your language
1
English